Eagle Pharmaceuticals
EGRX
#11130
Rank
A$4.89 M
Marketcap
A$0.37
Share price
0.00%
Change (1 day)
-80.62%
Change (1 year)

Eagle Pharmaceuticals (EGRX) - Total liabilities

Total liabilities on the balance sheet as of June 2023 : A$0.22 Billion

According to Eagle Pharmaceuticals 's latest financial reports the company's total liabilities are A$0.22 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eagle Pharmaceuticals - Total liabilities on balance sheet (from 2013 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$0.25 B137.94%
2021-12-31A$0.10 B22.01%
2020-12-31A$87.36 M-18.85%
2019-12-31A$0.10 B-2.56%
2018-12-31A$0.11 B-5.12%
2017-12-31A$0.11 B33.04%
2016-12-31A$87.53 M86.11%
2015-12-31A$47.03 M
2014-09-30A$23.25 M35.03%
2013-09-30A$17.21 M-17.2%
2012-09-30A$20.79 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
A$172.55 B 75,757.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$118.49 B 51,990.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
A$160.50 B 70,458.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$124.99 B 54,848.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$97.32 B 42,685.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$105.33 B 46,206.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$47.79 B 20,910.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel